Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives

In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with comorbidities such as diabetes, cardiovascular and ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Dejani, Naiara Naiana, Elshabrawy, Hatem A., Bezerra Filho, Carlos da Silva Maia, de Sousa, Damião Pergentino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394099/
https://www.ncbi.nlm.nih.gov/pubmed/34439920
http://dx.doi.org/10.3390/biom11081254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394099/
https://www.ncbi.nlm.nih.gov/pubmed/34439920
http://dx.doi.org/10.3390/biom11081254

Ejemplares similares